北米のスマートライフサイエンス製造市場の2028年までの予測- 地域別分析- コンポーネント別、技術別、最終用途産業別

北米のスマートライフサイエンス製造市場は、2023年の61億189万米ドルから2033年には225億7,568万米ドルに成長すると予測されます。2023年から2033年までのCAGRは14.0%と推定されます。

Pharma 4.0の採用が北米のスマートライフサイエンス製造市場を後押し

医療分野ではテクノロジーが大きな役割を果たしており、腫瘍学、神経学、免疫学などの他の分野に比べて、バイオテクノロジー産業はデータ分析における最近の技術進歩によって最も恩恵を受けている分野です。新たなデータサイエンス技術もバイオテクノロジー産業の成長を支援しています。生体の分析、新薬の研究などは、bIoTechnology研究所が果たす主要な役割です。

最新のデータ分析ツールにより、bIoTechnologyの研究者は予測分析モデルを作成できるようになり、最終的には望ましい目標や目的を達成するための最も効果的な方法を理解できるようになっています。ビッグデータ、AI、バーチャルリアリティ、データ可視化、データセキュリティは、バイオテクノロジー研究所で使用される一般的な技術の一つです。TableauはNovozymesのレポート作成時間を90％以上短縮するのに役立っています。また、販売、原材料購入、+計画、財務など、同社の各部門における戦略的意思決定も支援しています。さらに、TableauはNovozymesの営業部門が顧客と重要な洞察を共有することを可能にし、それによって関係を構築し、収益パフォーマンスを向上させています。

アストラゼネカ（AstraZeneca, plc）は、英国・スウェーデンの多国籍製薬・バイオテクノロジー企業で、データとテクノロジーを活用し、新薬候補の発見から提供までの時間を最短化しています。同社は研究開発部門にデータサイエンスとAIの能力を組み込んでおり、科学者は科学の限界を押し広げ、生命を変える医薬品を提供することができます。同社は、標的の特定から臨床試験まで、創薬・開発プロセス全体を通じてAIを適用し、創薬・開発プロセスを導く新たな知見を明らかにしています。カリフォルニアを拠点とするAtomwise社も、AIを活用して低分子医薬品の創薬を進めています。同社はUConnと提携し、COVID-19に対する創薬標的の調査でUConnの研究者と協力しています。

北米のスマートライフサイエンス製造市場の概要

北米は世界の先進地域の一つです。米国は、人工知能（AI）、モノのインターネット（IoT）、機械学習（ML）、クラウドコンピューティング、ビッグデータ分析などの先端技術の採用率が高いことから、ライフサイエンス市場におけるスマートライフサイエンス製造の最大シェアを占めています。北米地域は、マイクロソフト社やIBM社など様々なハイテク大手の存在とともに、こうした技術の採用が多いです。これらのハイテク企業は、ライフサイエンス＆ヘルスケア業界にテクノロジーを提供しています。さらに、この地域にはファイザーやGEヘルスケアといったライフサイエンス業界の大手メーカーが多数進出しています。これらのメーカーは、スマート製造技術を使って医薬品や医療機器を製造・生産しています。さらに、COVID-19パンデミックの間、安全性を確保するために従業員間の接触を制限した生産ユニットを自動化するために、スマート製造技術の使用が増加しました。例えば、2019年にフィリップスはハイブリッドクラウドモデルを構築するためのIT変革プログラムの設計と実施にアトスを選択しました。この契約は4年半にわたって行われ、フィリップスが顧客のニーズを満たす上で役立ち、進化するビジネスとテクノロジーの要件に柔軟に対応できるようになると期待されています。フィリップスのITトランスフォーメーションは、今後数年間でヘルスケアのイノベーションを促進すると期待されています。

北米のスマートライフサイエンス製造市場の収益と2033年までの予測（金額）

北米のスマートライフサイエンス製造市場のセグメンテーション

北米のスマートライフサイエンス製造市場は、技術、コンポーネント、最終用途産業、国に区分されます。

コンポーネントに基づいて、北米のスマートライフサイエンス製造市場はソリューションとサービスに区分されます。2023年の北米のスマートライフサイエンス製造市場では、ソリューションセグメントが大きなシェアを占めています。

技術に基づくセグメントは、AR/VRシステム、モノのインターネット（IOT）、人工知能（AI）、サイバーセキュリティ、ビッグデータ、その他に分類されます。2023年の北米のスマートライフサイエンス製造市場では、モノのインターネット分野が最大のシェアを占めています。

最終用途産業に基づいて、北米のスマートライフサイエンス製造市場は製薬、バイオ製薬、医療機器に区分されます。2023年の北米のスマートライフサイエンス製造市場では、医療機器分野が最大のシェアを占めています。

国別では、北米のスマートライフサイエンス製造市場は米国、カナダ、メキシコに区分されます。米国は2023年に北米のスマートライフサイエンス製造市場を独占しました。

ABB Ltd、Bosch Rexroth AG、Emerson Electric Co、Fortinet Inc、General Electric Co、Honeywell International Inc、International Business Machines Corp、Rockwell Automation Inc、Siemens AG、Sophos Ltdは、北米のスマートライフサイエンス製造市場で事業を展開する大手企業です。

目次

第1章 イントロダクション

第2章 北米のスマートライフサイエンス製造市場-要点

第3章 調査手法

• 調査範囲
• 2次調査
• 1次調査

第4章 北米のスマートライフサイエンス製造市場- 市場情勢

• 概観
• 北米のPEST分析
• エコシステム分析
• 専門家の見解

第5章 北米のスマートライフサイエンス製造市場：主要市場力学

• 市場促進要因
  • Pharma 4.0の採用増加
  • バイオテクノロジー研究所における技術利用の増加
• 市場抑制要因
  • スキルギャップの存在と高額な初期投資の必要性
• 市場機会
  • がん研究における人工知能の利用
  • スマート工場におけるバーチャルリアリティの採用
• 今後の動向
  • データサイロへの接続
  • ブロックチェーンの利用
  • エッジコンピューティング
  • 予知保全
  • ビジョンベースの品質管理
  • スマートファクトリーの動向
  • インダストリー5.0の出現
• 促進要因と抑制要因の影響分析

第6章 北米のスマートライフサイエンス製造市場-北米分析

第7章 北米のスマートライフサイエンス製造市場分析- コンポーネント別

• 北米のスマートライフサイエンス製造市場：コンポーネント別（2022年、2033年）
• ソリューション
• サービス

第8章 北米のスマートライフサイエンス製造市場分析-技術別

• 北米のスマートライフサイエンス製造市場：技術別（2022年・2033年）
• AR/VRシステム
• モノのインターネット（IOT）
• 人工知能
• サイバーセキュリティ
• ビッグデータ
• その他

第9章 北米のスマートライフサイエンス製造市場分析- 最終用途産業別

• 北米のスマートライフサイエンス製造市場：最終用途産業別（2022年・2033年）
• 製薬
• バイオファーマ
• 医療機器

第10章 北米のスマートライフサイエンス製造市場分析：国別

• 北米のスマートライフサイエンス製造市場、概要

第11章 業界情勢

• 市場の取り組み、拡大、戦略的開発
• 新製品／機能開発
• 合併と買収
• 契約、提携、合弁事業

第12章 企業プロファイル

• ABB Ltd
• Bosch Rexroth AG
• Emerson Electric Co
• Fortinet Inc
• General Electric Co
• Honeywell International Inc
• International Business Machines Corp
• Rockwell Automation Inc
• Siemens AG
• Sophos Ltd.

第13章 付録

List Of Tables

• Table 1. North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
• Table 2. US North America Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
• Table 3. US North America Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
• Table 4. US North America Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
• Table 5. US North America Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
• Table 6. Canada North America Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
• Table 7. Canada North America Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
• Table 8. Canada North America Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
• Table 9. Canada North America Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
• Table 10. Mexico North America Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
• Table 11. Mexico North America Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
• Table 12. Mexico North America Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
• Table 13. Mexico North America Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
• Table 14. List of Abbreviation

List Of Figures

• Figure 1. North America Smart Life Sciences Manufacturing Market Segmentation
• Figure 2. North America Smart Life Sciences Manufacturing Market Segmentation, By Country
• Figure 3. North America Smart Life Sciences Manufacturing Market Overview
• Figure 4. Solutions Held Largest Share of Component Segment in North America Smart Life Sciences Manufacturing Market
• Figure 5. North America Region Is Expected to Show Remarkable Growth During the Forecast Period
• Figure 6. North America: PEST Analysis
• Figure 7. Expert Opinion
• Figure 1. North America Smart Life Sciences Manufacturing Market: Impact Analysis of Drivers and Restraints
• Figure 2. North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
• Figure 3. North America Smart Life Sciences Manufacturing Market Revenue Share, By Component (2022 and 2033)
• Figure 4. Solutions: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• Figure 5. Services: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• Figure 6. North America Smart Life Sciences Manufacturing Market Revenue Share, By Technology (2022 and 2033)
• Figure 7. AR/VR System: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• Figure 8. Internet of Things (IOT): North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• Figure 9. Artificial Intelligence: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• Figure 10. Cyber Security: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• Figure 11. Big Data: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• Figure 12. Others: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• Figure 13. North America Smart Life Sciences Manufacturing Market Revenue Share, By End Use Industry (2022 and 2033)
• Figure 14. Pharma: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• Figure 15. Bio-Pharma : North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• Figure 16. Medical Device: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• Figure 17. North America Smart Life Sciences Manufacturing Market, by Key Country - Revenue (2022) (US$ Million)
• Figure 18. North America Smart Life Sciences Manufacturing Market Revenue Share, by Key Country, (2022 & 2033)
• Figure 19. US: North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
• Figure 20. Canada: North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
• Figure 21. Mexico: North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)

The North America Smart Life Sciences Manufacturing Market is expected to grow from US$ 6,101.89 million in 2023 to US$ 22,575.68 million by 2033. It is estimated to grow at a CAGR of 14.0% from 2023 to 2033.

Rising Adoption of Pharma 4.0 Fuel North America Smart Life Sciences Manufacturing Market

Technology has been playing a major role in the healthcare sector, wherein the biotechnology industry is the most benefited segment by recent technological advancements in data analytics, compared to other domains such as oncology, neurology, and immunology. Emerging data sciences technologies also assist in the growth of the bIoTechnology industry. The analysis of living organisms, research for novel drugs, etc., are the major roles played by bIoTechnology laboratories.

Modern data analytics tools have allowed bIoTechnology researchers to create predictive analytics models and eventually allow them to understand the most effective ways of achieving their desired goals and objectives. Big data, AI, virtual reality, data visualization, and data security are among the common technologies used in biotech laboratories. Tableau helped Novozymes cut the reporting times by more than 90%. It also assists in strategic decision-making within the company's departments such as sales, raw material purchase, +planning, and finance. In addition, Tableau allows Novozymes' sales force in sharing key insights with customers, thereby building relationships and enhancing revenue performance.

AstraZeneca, plc, a British-Swedish multinational pharmaceutical and bIoTechnology company, uses data and technology to minimize the time to discovery and delivery of potential new medicines. The company has data science and AI capabilities embedded in its R&D departments, which allows scientists to push the boundaries of science to deliver life-changing medicines. They apply AI throughout the discovery and development process, from target identification to clinical trials, to uncover new insights guiding the drug discovery and development process. Atomwise, a California-based company, also uses AI to advance small molecule drug discovery. The company partnered with Uconn to collaborate with UConn researchers on the investigation of drug targets against COVID-19.

North America Smart Life Sciences Manufacturing Market Overview

North America is one of the developed regions across the world. The US holds the largest share of the smart life sciences manufacturing in life science market owing to high adoption of advance technologies such as artificial intelligence (AI), Internet of Things (IoT), machine learning (ML), cloud computing, and big data analytics. The North American region has high adoption of such technologies along with the presence of various tech giants such as Microsoft Corporation and IBM Corporation. These tech companies provide technologies to the life sciences & healthcare industry. Additionally, the region houses various major manufacturers from the life science industry such as Pfizer and GE HealthCare. These manufacturers use smart manufacturing technologies to produce and manufacture pharmaceutical and medical devices. Moreover, during COVID-19 pandemic, the use of smart manufacturing technologies increased to automate the production units with limited contact among employees to ensure safety. For instance, in 2019 Phillips selected Atos to design and implement an IT transformation program to build a hybrid cloud model. The deal was done for four and a half years and is expected to help Philips in meeting the needs of their customers and provides flexibility to meet its evolving business and technology requirements. The IT transformation of Phillips is expected to drive healthcare innovation in the coming years.

North America Smart Life Sciences Manufacturing Market Revenue and Forecast to 2033 (US$ Million)

North America Smart Life Sciences Manufacturing Market Segmentation

The North America smart life sciences manufacturing market is segmented into technology, component, end use industry, and country.

Based on component, the North America smart life sciences manufacturing market is segmented into solutions and services. The solution segment held a larger share of the North America smart life sciences manufacturing market in 2023.

Based on technology segment is categorized into AR/VR Systems, Internet of things (IOT), Artificial Intelligence (AI), Cybersecurity, Big Data, and others. The Internet of things segment held the largest share of the North America smart life sciences manufacturing market in 2023.

Based on end use industry, the North America smart life sciences manufacturing market is segmented into pharma, bio-pharma, and medical devices. The medical device segment held the largest share of the North America smart life sciences manufacturing market in 2023.

Based on country, the North America smart life sciences manufacturing market is segmented into the US, Canada, and Mexico. The US dominated the North America smart life sciences manufacturing market in 2023.

ABB Ltd, Bosch Rexroth AG, Emerson Electric Co, Fortinet Inc, General Electric Co, Honeywell International Inc, International Business Machines Corp, Rockwell Automation Inc, Siemens AG, and Sophos Ltd are some of the leading companies operating in the North America smart life sciences manufacturing market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Smart Life Sciences Manufacturing Market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in North America Smart Life Sciences Manufacturing Market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth North America Market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

• 1.1 Scope of the Study
• 1.2 The Insight Partners Research Report Guidance
• 1.3 Market Segmentation
  • 1.3.1 North America Smart Life Sciences Manufacturing Market - By Component
  • 1.3.2 North America Smart Life Sciences Manufacturing Market - By Technology
  • 1.3.3 North America Smart Life Sciences Manufacturing Market - By End Use Industry
  • 1.3.4 North America Smart Life Sciences Manufacturing Market - By Country

2. North America Smart Life Sciences Manufacturing Market - Key Takeaways

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. North America Smart Life Sciences Manufacturing Market - Market Landscape

• 4.1 Overview
• 4.2 North America PEST Analysis
• 4.3 Ecosystem Analysis
• 4.4 Expert Opinion

5. North America Smart Life Sciences Manufacturing Market - Key Market Dynamics

• 5.1 Market Drivers
  • 5.1.1 Rising Adoption of Pharma 4.0
  • 5.1.2 Increasing Use of Technologies in Biotechnology Laboratories
• 5.2 Market Restraints
  • 5.2.1 Presence of Skill Gap and Need for High Initial Investment
• 5.3 Market Opportunities
  • 5.3.1 Use of Artificial Intelligence in Cancer Research
  • 5.3.2 Adoption of Virtual Reality in Smart Factory
• 5.4 Future Trends
  • 5.4.1 Connection to Data Silos
  • 5.4.2 Usage of Blockchain
  • 5.4.3 Edge Computing
  • 5.4.4 Predictive Maintenance
  • 5.4.5 Vision-Based Quality Management
  • 5.4.6 Smart Factory Trends
  • 5.4.7 Emergence of Industry 5.0
• 5.5 Impact Analysis of Drivers and Restraints

6. North America Smart Life Sciences Manufacturing Market - North America Analysis

• 6.1 Overview
• 6.2 North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)

7. North America Smart Life Sciences Manufacturing Market Analysis - By Component

• 7.1 Overview
• 7.2 North America Smart Life Sciences Manufacturing Market, By Component (2022 and 2033)
• 7.3 Solutions
  • 7.3.1 Overview
  • 7.3.2 Solutions: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• 7.4 Services
  • 7.4.1 Overview
  • 7.4.2 Services: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

8. North America Smart Life Sciences Manufacturing Market Analysis - By Technology

• 8.1 Overview
• 8.2 North America Smart Life Sciences Manufacturing Market, By Technology (2022 and 2033)
• 8.3 AR/VR System
  • 8.3.1 Overview
  • 8.3.2 AR/VR System: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• 8.4 Internet of Things (IOT)
  • 8.4.1 Overview
  • 8.4.2 Internet of Things (IOT): North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• 8.5 Artificial Intelligence
  • 8.5.1 Overview
  • 8.5.2 Artificial Intelligence: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• 8.6 Cyber Security
  • 8.6.1 Overview
  • 8.6.2 Cyber Security: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• 8.7 Big Data
  • 8.7.1 Overview
  • 8.7.2 Big Data: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• 8.8 Others
  • 8.8.1 Overview
  • 8.8.2 Others: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

9. North America Smart Life Sciences Manufacturing Market Analysis - By End Use Industry

• 9.1 Overview
• 9.2 North America Smart Life Sciences Manufacturing Market, by End Use Industry (2022 and 2033)
• 9.3 Pharma
  • 9.3.1 Overview
  • 9.3.2 Pharma: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• 9.4 Bio-Pharma
  • 9.4.1 Overview
  • 9.4.2 Bio-Pharma: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
• 9.5 Medical Device
  • 9.5.1 Overview
  • 9.5.2 Medical Device: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

10. North America Smart Life Sciences Manufacturing Market Analysis - By Country

• 10.1 North America: North America Smart Life Sciences Manufacturing Market Overview
  • 10.1.1.1 US: North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
    • 10.1.1.1.1 Overview
    • 10.1.1.1.2 US: North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
    • 10.1.1.1.3 US: North America Smart Life Sciences Manufacturing Market, by Component, 2022-2033 (US$ Million)
    • 10.1.1.1.4 US: North America Smart Life Sciences Manufacturing Market, by Technology, 2022-2033 (US$ Million)
    • 10.1.1.1.4.1 US: North America Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022-2033 (US$ Million)
    • 10.1.1.1.5 US North America Smart Life Sciences Manufacturing Market, by End Use Industry, 2022-2033 (US$ Million)
  • 10.1.1.2 Canada: North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
    • 10.1.1.2.1 Overview
    • 10.1.1.2.2 Canada: North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
    • 10.1.1.2.3 Canada: North America Smart Life Sciences Manufacturing Market, by Component, 2022-2033 (US$ Million)
    • 10.1.1.2.4 Canada: North America Smart Life Sciences Manufacturing Market, by Technology, 2022-2033 (US$ Million)
    • 10.1.1.2.4.1 Canada: North America Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022-2033 (US$ Million)
    • 10.1.1.2.5 Canada: North America Smart Life Sciences Manufacturing Market, by End Use Industry, 2022-2033 (US$ Million)
  • 10.1.1.3 Mexico: North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
    • 10.1.1.3.1 Overview
    • 10.1.1.3.2 Mexico: North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
    • 10.1.1.3.3 Mexico: North America Smart Life Sciences Manufacturing Market, by Component, 2022-2033 (US$ Million)
    • 10.1.1.3.4 Mexico: North America Smart Life Sciences Manufacturing Market, by Technology, 2022-2033 (US$ Million)
    • 10.1.1.3.4.1 Mexico: North America Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022-2033 (US$ Million)
    • 10.1.1.3.5 Mexico: North America Smart Life Sciences Manufacturing Market, by End Use Industry, 2022-2033 (US$ Million)

11. Industry Landscape

• 11.1 Overview
• 11.2 Market Initiatives, Expansions, and Strategic Developments
• 11.3 New Product/Feature Development
• 11.4 Mergers and Acquisitions
• 11.5 Agreements, Collaborations, and Joint Ventures

12. Company Profile

• 12.1 ABB Ltd
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 Bosch Rexroth AG
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 Emerson Electric Co
  • 12.3.1 Business Description
  • 12.3.2 Products and Services
  • 12.3.3 Financial Overview
  • 12.3.4 SWOT Analysis
  • 12.3.5 Key Developments
• 12.4 Fortinet Inc
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 General Electric Co
  • 12.5.1 Business Description
  • 12.5.2 Products and Services
  • 12.5.3 Financial Overview
  • 12.5.4 SWOT Analysis
  • 12.5.5 Key Developments
• 12.6 Honeywell International Inc
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
• 12.7 International Business Machines Corp
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
• 12.8 Rockwell Automation Inc
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
• 12.9 Siemens AG
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
• 12.10 Sophos Ltd.
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments

13. Appendix

• 13.1 About The Insight Partners
• 13.2 Word Index